Global and United States Dihydroartemisinin Market Insights, Forecast to 2026

Global and United States Dihydroartemisinin Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Dihydroartemisinin Product Introduction
1.2 Market Segments
1.3 Key Dihydroartemisinin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dihydroartemisinin Market Size Growth Rate by Type
1.4.2 Pharmaceutical Grade
1.4.3 Industrial Grade
1.5 Market by Application
1.5.1 Global Dihydroartemisinin Market Size Growth Rate by Application
1.5.2 Malaria Treatment
1.5.3 Scientific Research
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dihydroartemisinin Market Size, Estimates and Forecasts
2.1.1 Global Dihydroartemisinin Revenue 2015-2026
2.1.2 Global Dihydroartemisinin Sales 2015-2026
2.2 Global Dihydroartemisinin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Dihydroartemisinin Historical Market Size by Region (2015-2020)
2.3.1 Global Dihydroartemisinin Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Dihydroartemisinin Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Dihydroartemisinin Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Dihydroartemisinin Sales Forecast by Region (2021-2026)
2.4.2 Global Dihydroartemisinin Revenue Forecast by Region (2021-2026)
3 Global Dihydroartemisinin Competitor Landscape by Players
3.1 Global Top Dihydroartemisinin Sales by Manufacturers
3.1.1 Global Dihydroartemisinin Sales by Manufacturers (2015-2020)
3.1.2 Global Dihydroartemisinin Sales Market Share by Manufacturers (2015-2020)
3.2 Global Dihydroartemisinin Manufacturers by Revenue
3.2.1 Global Dihydroartemisinin Revenue by Manufacturers (2015-2020)
3.2.2 Global Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dihydroartemisinin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2019
3.2.5 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dihydroartemisinin Price by Manufacturers
3.4 Global Dihydroartemisinin Manufacturing Base Distribution, Product Types
3.4.1 Dihydroartemisinin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dihydroartemisinin Product Type
3.4.3 Date of International Manufacturers Enter into Dihydroartemisinin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dihydroartemisinin Market Size by Type (2015-2020)
4.1.1 Global Dihydroartemisinin Sales by Type (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue by Type (2015-2020)
4.1.3 Dihydroartemisinin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dihydroartemisinin Market Size Forecast by Type (2021-2026)
4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
4.2.3 Dihydroartemisinin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dihydroartemisinin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dihydroartemisinin Market Size by Application (2015-2020)
5.1.1 Global Dihydroartemisinin Sales by Application (2015-2020)
5.1.2 Global Dihydroartemisinin Revenue by Application (2015-2020)
5.1.3 Dihydroartemisinin Price by Application (2015-2020)
5.2 Dihydroartemisinin Market Size Forecast by Application (2021-2026)
5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Dihydroartemisinin Market Size YoY Growth 2015-2026
6.1.1 United States Dihydroartemisinin Sales YoY Growth 2015-2026
6.1.2 United States Dihydroartemisinin Revenue YoY Growth 2015-2026
6.1.3 United States Dihydroartemisinin Market Share in Global Market 2015-2026
6.2 United States Dihydroartemisinin Market Size by Players (International and Local Players)
6.2.1 United States Top Dihydroartemisinin Players by Sales (2015-2020)
6.2.2 United States Top Dihydroartemisinin Players by Revenue (2015-2020)
6.3 United States Dihydroartemisinin Historic Market Review by Type (2015-2020)
6.3.1 United States Dihydroartemisinin Sales Market Share by Type (2015-2020)
6.3.2 United States Dihydroartemisinin Revenue Market Share by Type (2015-2020)
6.3.3 United States Dihydroartemisinin Price by Type (2015-2020)
6.4 United States Dihydroartemisinin Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Dihydroartemisinin Sales Forecast by Type (2021-2026)
6.4.2 United States Dihydroartemisinin Revenue Forecast by Type (2021-2026)
6.4.3 United States Dihydroartemisinin Price Forecast by Type (2021-2026)
6.5 United States Dihydroartemisinin Historic Market Review by Application (2015-2020)
6.5.1 United States Dihydroartemisinin Sales Market Share by Application (2015-2020)
6.5.2 United States Dihydroartemisinin Revenue Market Share by Application (2015-2020)
6.5.3 United States Dihydroartemisinin Price by Application (2015-2020)
6.6 United States Dihydroartemisinin Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Dihydroartemisinin Sales Forecast by Application (2021-2026)
6.6.2 United States Dihydroartemisinin Revenue Forecast by Application (2021-2026)
6.6.3 United States Dihydroartemisinin Price Forecast by Application (2021-2026)
7 North America
7.1 North America Dihydroartemisinin Market Size YoY Growth 2015-2026
7.2 North America Dihydroartemisinin Market Facts & Figures by Country
7.2.1 North America Dihydroartemisinin Sales by Country (2015-2020)
7.2.2 North America Dihydroartemisinin Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Dihydroartemisinin Market Size YoY Growth 2015-2026
8.2 Europe Dihydroartemisinin Market Facts & Figures by Country
8.2.1 Europe Dihydroartemisinin Sales by Country
8.2.2 Europe Dihydroartemisinin Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Dihydroartemisinin Market Size YoY Growth 2015-2026
9.2 Asia Pacific Dihydroartemisinin Market Facts & Figures by Country
9.2.1 Asia Pacific Dihydroartemisinin Sales by Region (2015-2020)
9.2.2 Asia Pacific Dihydroartemisinin Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Dihydroartemisinin Market Size YoY Growth 2015-2026
10.2 Latin America Dihydroartemisinin Market Facts & Figures by Country
10.2.1 Latin America Dihydroartemisinin Sales by Country
10.2.2 Latin America Dihydroartemisinin Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dihydroartemisinin Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Country
11.2.1 Middle East and Africa Dihydroartemisinin Sales by Country
11.2.2 Middle East and Africa Dihydroartemisinin Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Dihydroartemisinin Products Offered
12.1.5 Sanofi Recent Development
12.2 KPC Pharmaceuticals
12.2.1 KPC Pharmaceuticals Corporation Information
12.2.2 KPC Pharmaceuticals Description and Business Overview
12.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
12.2.5 KPC Pharmaceuticals Recent Development
12.3 Guangxi Xiancaotang Pharmaceutical
12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
12.3.2 Guangxi Xiancaotang Pharmaceutical Description and Business Overview
12.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
12.4 Guilin Pharmaceutical
12.4.1 Guilin Pharmaceutical Corporation Information
12.4.2 Guilin Pharmaceutical Description and Business Overview
12.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
12.4.5 Guilin Pharmaceutical Recent Development
12.5 Kerui Nanhai Pharmaceutical
12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
12.5.2 Kerui Nanhai Pharmaceutical Description and Business Overview
12.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
12.5.5 Kerui Nanhai Pharmaceutical Recent Development
12.6 Shanghai Natural Bio-engineering Co
12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
12.6.2 Shanghai Natural Bio-engineering Co Description and Business Overview
12.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
12.6.5 Shanghai Natural Bio-engineering Co Recent Development
12.7 Novanat Bioresource
12.7.1 Novanat Bioresource Corporation Information
12.7.2 Novanat Bioresource Description and Business Overview
12.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
12.7.5 Novanat Bioresource Recent Development
12.8 Botanical Extracts EPZ Ltd
12.8.1 Botanical Extracts EPZ Ltd Corporation Information
12.8.2 Botanical Extracts EPZ Ltd Description and Business Overview
12.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
12.8.5 Botanical Extracts EPZ Ltd Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi Dihydroartemisinin Products Offered
12.11.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dihydroartemisinin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Dihydroartemisinin Market Segments
Table 2. Ranking of Global Top Dihydroartemisinin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dihydroartemisinin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pharmaceutical Grade
Table 5. Major Manufacturers of Industrial Grade
Table 6. Global Dihydroartemisinin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Dihydroartemisinin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Dihydroartemisinin Sales by Regions 2015-2020 (K MT)
Table 9. Global Dihydroartemisinin Sales Market Share by Regions (2015-2020)
Table 10. Global Dihydroartemisinin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Dihydroartemisinin Sales Forecast by Region (2021-2026) (K MT)
Table 12. Global Dihydroartemisinin Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Dihydroartemisinin Sales Share by Manufacturers (2015-2020)
Table 14. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2019)
Table 16. Dihydroartemisinin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Dihydroartemisinin Price (2015-2020) (USD/MT)
Table 19. Dihydroartemisinin Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Dihydroartemisinin Product Type
Table 21. Date of International Manufacturers Enter into Dihydroartemisinin Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 24. Global Dihydroartemisinin Sales Share by Type (2015-2020)
Table 25. Global Dihydroartemisinin Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Dihydroartemisinin Revenue Share by Type (2015-2020)
Table 27. Dihydroartemisinin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Dihydroartemisinin Sales Share by Type (2021-2026)
Table 29. Global Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 30. Global Dihydroartemisinin Sales Share by Application (2015-2020)
Table 31. Global Dihydroartemisinin Sales Share by Application (2021-2026)
Table 32. Global Dihydroartemisinin Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Dihydroartemisinin Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Dihydroartemisinin Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Dihydroartemisinin Sales (K MT) of Key Companies (2015-2020)
Table 36. United States Dihydroartemisinin Sales Share by Company (2015-2020)
Table 37. United States Dihydroartemisinin Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 39. United States Dihydroartemisinin Sales Share by Type (2015-2020)
Table 40. United States Dihydroartemisinin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Dihydroartemisinin Price (K MT) by Type (2015-2020)
Table 42. United States Dihydroartemisinin Sales (K MT) by Type (2021-2026)
Table 43. United States Dihydroartemisinin Sales Share by Type (2021-2026)
Table 44. United States Dihydroartemisinin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Dihydroartemisinin Revenue Share by Type (2021-2026)
Table 46. United States Dihydroartemisinin Price (K MT) by Type (2021-2026)
Table 47. United States Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 48. United States Dihydroartemisinin Sales Share by Application (2015-2020)
Table 49. United States Dihydroartemisinin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Dihydroartemisinin Sales (K MT) by Application (2021-2026)
Table 51. United States Dihydroartemisinin Sales Share by Application (2021-2026)
Table 52. United States Dihydroartemisinin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Dihydroartemisinin Revenue Share by Application (2021-2026)
Table 54. North America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 55. North America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 56. North America Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 58. Europe Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 59. Europe Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 60. Europe Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Dihydroartemisinin Sales by Region (2015-2020) (K MT)
Table 63. Asia Pacific Dihydroartemisinin Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Dihydroartemisinin Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Table 66. Latin America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 67. Latin America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Business Overview
Table 76. Sanofi Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi Dihydroartemisinin Product
Table 78. Sanofi Recent Development
Table 79. KPC Pharmaceuticals Corporation Information
Table 80. KPC Pharmaceuticals Description and Business Overview
Table 81. KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. KPC Pharmaceuticals Product
Table 83. KPC Pharmaceuticals Recent Development
Table 84. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 85. Guangxi Xiancaotang Pharmaceutical Description and Business Overview
Table 86. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Guangxi Xiancaotang Pharmaceutical Product
Table 88. Guangxi Xiancaotang Pharmaceutical Recent Development
Table 89. Guilin Pharmaceutical Corporation Information
Table 90. Guilin Pharmaceutical Description and Business Overview
Table 91. Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Guilin Pharmaceutical Product
Table 93. Guilin Pharmaceutical Recent Development
Table 94. Kerui Nanhai Pharmaceutical Corporation Information
Table 95. Kerui Nanhai Pharmaceutical Description and Business Overview
Table 96. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Kerui Nanhai Pharmaceutical Product
Table 98. Kerui Nanhai Pharmaceutical Recent Development
Table 99. Shanghai Natural Bio-engineering Co Corporation Information
Table 100. Shanghai Natural Bio-engineering Co Description and Business Overview
Table 101. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Shanghai Natural Bio-engineering Co Product
Table 103. Shanghai Natural Bio-engineering Co Recent Development
Table 104. Novanat Bioresource Corporation Information
Table 105. Novanat Bioresource Description and Business Overview
Table 106. Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Novanat Bioresource Product
Table 108. Novanat Bioresource Recent Development
Table 109. Botanical Extracts EPZ Ltd Corporation Information
Table 110. Botanical Extracts EPZ Ltd Description and Business Overview
Table 111. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Botanical Extracts EPZ Ltd Product
Table 113. Botanical Extracts EPZ Ltd Recent Development
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Dihydroartemisinin Players
Table 118. Dihydroartemisinin Customers List
Table 119. Dihydroartemisinin Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Dihydroartemisinin Product Picture
Figure 2. Global Dihydroartemisinin Sales Market Share by Type in 2020 & 2026
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Dihydroartemisinin Sales Market Share by Application in 2020 & 2026
Figure 6. Malaria Treatment
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Dihydroartemisinin Report Years Considered
Figure 10. Global Dihydroartemisinin Market Size 2015-2026 (US$ Million)
Figure 11. Global Dihydroartemisinin Sales 2015-2026 (K MT)
Figure 12. Global Dihydroartemisinin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dihydroartemisinin Sales Market Share by Region (2015-2020)
Figure 14. Global Dihydroartemisinin Sales Market Share by Region in 2019
Figure 15. Global Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Figure 16. Global Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 17. Global Dihydroartemisinin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dihydroartemisinin Revenue in 2019
Figure 19. Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dihydroartemisinin Sales Market Share by Type (2015-2020)
Figure 21. Global Dihydroartemisinin Sales Market Share by Type in 2019
Figure 22. Global Dihydroartemisinin Revenue Market Share by Type (2015-2020)
Figure 23. Global Dihydroartemisinin Revenue Market Share by Type in 2019
Figure 24. Global Dihydroartemisinin Market Share by Price Range (2015-2020)
Figure 25. Global Dihydroartemisinin Sales Market Share by Application (2015-2020)
Figure 26. Global Dihydroartemisinin Sales Market Share by Application in 2019
Figure 27. Global Dihydroartemisinin Revenue Market Share by Application (2015-2020)
Figure 28. Global Dihydroartemisinin Revenue Market Share by Application in 2019
Figure 29. United States Dihydroartemisinin Sales Growth Rate 2015-2026 (K MT)
Figure 30. United States Dihydroartemisinin Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Dihydroartemisinin Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Dihydroartemisinin Players Market Share by Revenue in Dihydroartemisinin in 2019
Figure 33. United States Dihydroartemisinin Revenue Share by Type (2015-2020)
Figure 34. United States Dihydroartemisinin Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Dihydroartemisinin Revenue Share by Application (2015-2020)
Figure 36. United States Dihydroartemisinin Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 40. North America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 41. U.S. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Dihydroartemisinin Sales Market Share by Country in 2019
Figure 48. Europe Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 49. Germany Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Dihydroartemisinin Sales Market Share by Region in 2019
Figure 62. Asia Pacific Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 63. China Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 88. Latin America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 89. Mexico Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Dihydroartemisinin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 99. Turkey Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Dihydroartemisinin Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs